XML 35 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-based Compensation Expense
A summary of stock-based compensation expense for the three months ended March 31, 2017 and 2016 is as follows:
 
Three Months Ended March 31,
 
2017
 
2016
 
(in thousands)
Stock options
$
1,172

 
$
878

Restricted stock and restricted stock units
287

 
135

Employee Stock Purchase Plan
121

 
105

Total pre-tax stock-based compensation expense charged against income (1)
$
1,580

 
$
1,118


(1) 
Stock-based compensation expense is recorded in selling, general and administrative expense in our Consolidated Statements of Comprehensive Income.
Summary of Other Information of Stock Option Plans
A summary of our stock options outstanding under the Plan as of December 31, 2016 and changes during the three months ended March 31, 2017 is as follows:
 
Stock Options Outstanding
 
Number of Shares
 
Weighted Average Exercise Price
 
(in thousands)
 
 
December 31, 2016
2,615

 
$
24.61

Granted
544

 
$
39.38

Cancelled
(39
)
 
$
33.82

Exercised
(201
)
 
$
23.31

March 31, 2017
2,919

 
$
27.33

Assumption For Fair Value of Options Granted
The fair value of stock option awards granted in 2017 and 2016 was estimated on the date of grant using the Black-Scholes option valuation model using the following assumptions:
 
Three Months Ended
 
2017
 
2016
Risk-free interest rate
2.0
%
 
2.0
%
Weighted average expected life (years)
5.8 years

 
5.8 years

Expected volatility
25.1
%
 
26.0
%
Dividend yield
1.9
%
 
2.0
%
Summarized Information of Stock Options Outstanding
The following table summarizes other information about our stock options at March 31, 2017:
 
 
March 31, 2017
 
 
(in thousands, except per share data)
Outstanding:
 
 
Aggregate intrinsic value
 
$
46,007

Weighted average remaining contractual life (years)
 
6.7 years

Exercisable:
 
 
Number of options
 
1,437

Weighted average exercise price
 
$
20.50

Aggregate intrinsic value
 
$
32,464

Weighted average remaining contractual life (years)
 
4.8 years

Schedule of Restricted Stock Outstanding Stock-based Compensation
A summary of our outstanding restricted stock awards as of December 31, 2016 and changes during the three months ended March 31, 2017 is as follows:
 
Shares
 
Weighted Average Grant Date Fair Value
 
(in thousands)
 
 
December 31, 2016
74

 
$
32.09

Granted

 
$

Vested
(18
)
 
$
31.41

Forfeited

 
$

March 31, 2017
56

 
$
32.30

A summary of our outstanding restricted stock units as of December 31, 2016 and changes during the three months ended March 31, 2017 is as follows:
 
Units
 
Weighted Average Grant Date Fair Value
 
(in thousands)
 
 
December 31, 2016

 
$

Granted
81

 
$
39.38

Vested

 
$

Forfeited

 
$

March 31, 2017
81

 
$
39.38

Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The stock-based compensation expense associated with the options granted in 2017 and 2016 under our ESPP was estimated on the date of grant using the Black-Scholes option valuation model using the following assumptions:
 
Three Months Ended March 31,
 
2017
 
2016
Risk-free interest rate
1.05%
 
0.58%
Weighted average expected life (years)
1.0
 
1.0
Expected volatility
21.2%
 
19.7%
Dividend yield
1.9%
 
2.0%
Schedule of Deferred Compensation Arrangement with Individual, Share-based Payments
The following table summarizes information about our SERP during the three months ended March 31, 2017 and 2016:
 
Three Months Ended March 31,
 
2017
 
2016
 
(in thousands)
SERP expense (1)
$
160

 
$
164

Unrealized gain (loss) recorded in SERP liability account
$
1,161

 
$
(328
)

(1) Both the SERP match and the deferrals are included in the selling, general and administrative caption in our consolidated statements of comprehensive income.